Treatment and Daily Management

Because there is currently no cure for APBD, your medical care will focus on symptom management—tailoring treatments to improve your mobility, protect your organs, and maintain your quality of life. This requires a multidisciplinary team of specialists, including neurologists, urologists, and physical therapists, who work together to address the different ways the disease affects your body ^[1][2].

Managing Your Bladder and Kidney Health

The most critical part of daily APBD management is monitoring your neurogenic bladder. When the bladder doesn’t empty fully, incomplete emptying, high bladder pressures, urine reflux, and recurrent infections can cause permanent kidney damage ^[3][4].

• Intermittent Catheterization: If your bladder cannot empty on its own, your neuro-urologist may recommend clean intermittent catheterization (CIC) after assessing your post-void residual and bladder pressures, often using a urodynamic study. This involves using a small, disposable tube several times a day to fully drain the bladder. While highly useful to prevent overflow accidents and protect kidneys, it is not automatically required for every patient and carries risks like urethral trauma or infection ^[4].
• Medications: Doctors may prescribe drugs to help the bladder relax (for urgency) or to help the “neck” of the bladder open more easily. Safety warning: Bladder-relaxing drugs (antimuscarinics) can worsen urinary retention and cognitive side effects, while alpha-blockers can worsen low blood pressure. Do not start, stop, or change these without your treating clinician ^[4].
• Vigilance: You must stay alert for signs of a Urinary Tract Infection (UTI). In APBD, a severe UTI can cause a sudden, temporary “crash” in your ability to walk or think clearly ^[4].

Mobility, Spasticity, and Balance

Managing the stiffness (spasticity) in your legs is a delicate balance. The goal is to reduce discomfort without making your muscles so relaxed that they become too weak to support your weight ^[5].

• Physical Therapy: Regular stretching and “task-specific” training (like balance and gait exercises) are essential. Some specialized centers use robot-assisted gait training to help maintain walking patterns ^[6][7].
• Medications: Oral drugs like baclofen or tizanidine can help reduce muscle tightness. Because these can cause severe sleepiness, weakness, dizziness, and falls, your doctor will likely start with a very low dose. Baclofen should never be stopped abruptly ^[5][8].
• Assistive Devices: Using a cane, walker, or wheelchair is not a “defeat”—it is a tool to stay active and prevent dangerous falls ^[9].
• Blood Pressure Support: If you feel dizzy when standing (orthostatic hypotension), simple steps like wearing compression stockings and staying well-hydrated can help stabilize your blood pressure ^[10]. Note that this advice must be balanced against any kidney, heart, or bladder restrictions you have.

What the Research Says About Diet and Triheptanoin

You may find information online about specialized diets or a synthetic oil called triheptanoin. It is important to know the results of the clinical trials:

• Triheptanoin Trials: In a study of 23 adults with APBD, triheptanoin was compared to a placebo. After one year, there was no statistically significant benefit in how far patients could walk, their stair-climbing ability, or their overall symptoms. It is not an established disease-modifying treatment ^[11].
• Metabolic Diets: While nutrition is important for general health, high-fat/low-carbohydrate (ketogenic-style) diets have not been proven to stop or reverse the progression of APBD. Extreme diets should not be attempted outside individualized nutritional supervision, as they can cause harm ^[11][12].

Future Horizons: Preclinical Research

While there are no disease-modifying treatments available for humans today, scientists are working on several exciting “preclinical” (animal and cell-based) strategies:

• Glycogen Synthase Suppression: Researchers have found that reducing the amount of glycogen your body makes in the first place can prevent the buildup of toxic polyglucosan bodies in mice ^[13][14].
• Gene Editing (CRISPR): Early studies in mice have used CRISPR technology to “turn down” the production of problematic glycogen enzymes ^[15].
• Antisense Oligonucleotides (ASOs): For patients with specific genetic mutations, ASOs are being developed in laboratory human cells to help the body “skip over” the error. This approach is mechanism-specific and not yet ready for human trials ^[16][17].

These technologies represent the next wave of research, but they must undergo years of safety testing before they can be used in patients. In the meantime, your best approach is proactive, multidisciplinary care.